home | services | BMA sampling guidance
Bone marrow sampling guidance (including MRD)
Sampling by indication
At diagnosis/relapse of acute leukaemia (AML or ALL) or pancytopenia of unknown cause
AML follow-up post-therapy (including MRD)
ALL follow-up post-therapy (including MRD)
MPN (including CML) and MDS or unexplained cytopenia